Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Glaser

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|July 1, 1996
Berlex continues legal challenge to FDA over MS drugV Glaser
Nature Biotechnology|October 1, 1996
Can ReoPro repolish tarnished monoclonal therapeutics?V Glaser
New York State Journal of Medicine|January 1, 1990
Risk factors for teenage suicideV Glaser
Bio/Technology (Nature Publishing Company)|October 1, 1995
Pharmacia challenges Genentech in rhGH marketV Glaser
New York State Journal of Medicine|May 1, 1988
The effect of zidovudine on antigen levels in HIV infectionV Glaser
Nature Biotechnology|July 17, 1999
Genentech relaunched with independence intactV Glaser
Nature Biotechnology|June 3, 2000
Cloned cows turn back the cellular clockV Glaser
Molecular Medicine Today|May 1, 1996
RNase L and 2-5A to enhance antisense technology and target the destruction of mRNAV Glaser
Bio/Technology (Nature Publishing Company)|September 1, 1995
U.S. skin replacement market could heat upV Glaser
New York State Journal of Medicine|May 1, 1990
Soluble CD4: a new antiviral treatment for AIDSV Glaser
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|July 1, 1996
Berlex continues legal challenge to FDA over MS drugV Glaser
Nature Biotechnology|October 1, 1996
Can ReoPro repolish tarnished monoclonal therapeutics?V Glaser
New York State Journal of Medicine|January 1, 1990
Risk factors for teenage suicideV Glaser
Bio/Technology (Nature Publishing Company)|October 1, 1995
Pharmacia challenges Genentech in rhGH marketV Glaser
New York State Journal of Medicine|May 1, 1988
The effect of zidovudine on antigen levels in HIV infectionV Glaser
Nature Biotechnology|July 17, 1999
Genentech relaunched with independence intactV Glaser
Nature Biotechnology|June 3, 2000
Cloned cows turn back the cellular clockV Glaser
Molecular Medicine Today|May 1, 1996
RNase L and 2-5A to enhance antisense technology and target the destruction of mRNAV Glaser
Bio/Technology (Nature Publishing Company)|September 1, 1995
U.S. skin replacement market could heat upV Glaser
New York State Journal of Medicine|May 1, 1990
Soluble CD4: a new antiviral treatment for AIDSV Glaser
Pageof 7